Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis

Author

OHASHI, Kazuteru¹ ; NAGAMURA-INOUE, Tokiko^{2 3} ; ATSUTA, Yoshiko^{13 14} ; SAKAMAKI, Hisashi^{1 14} ; NAGAMURA, Fumitaka⁴ ; TOJO, Arinobu⁵ ; MIYAMURA, Kouichi⁶ ; MORI, Takehiko⁷ ; KUROKAWA, Mineo⁸ ; TANIGUCHI, Shuichi⁹ ; ISHIKAVVA, Jun¹⁰ ; MORISHIMA, Yasuo^{11 12}
[1] Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan
[2] Department of Cell Processing and Transfusion, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
[3] Japan Cord Blood Bank Network, Tokyo, Japan
[4] Division of Clinical Trial Safety Management, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
[5] Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
[6] Department of Hematology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan
[7] Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
[8] Department of Cell Therapy and Transplantation Medicine, The University of Tokyo, Tokyo, Japan
[9] Department of Hematology, Toranomon Hospital, Tokyo, Japan
[10] Department of Hematology and Chemotherapy, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
[11] Division of Epidemiology/Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
[12] Japan Marrow Donor Program, Tokyo, Japan
[13] Department of HSCT Data Management/Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan
[14] Japanese Society of Hematopoietic Cell Transplantation, Nagoya, Japan

Source

International journal of hematology. 2014, Vol 100, Num 3, pp 296-306, 11 p ; ref : 25 ref

ISSN

0925-5710

Scientific domain

Hematology

Publisher

Springer, Heidelberg

Publication country

Germany

Document type

Article

Language

English

Author keyword

Allogeneic hematopoietic stem cell transplantation Chronic myeloid leukemia Graft sources

Keyword (fr)

Adulte Cellule hématopoïétique Cellule souche Homogreffe Hématologie Inhibiteur de la tyrosine kinase Leucémie myéloïde chronique Pronostic Rétrospective Allogreffe de cellules souches hématopoïétiques Greffe de cellules souches hématopoïétiques Japon Cancer Homme Hémopathie maligne Syndrome myéloprolifératif Asie

Keyword (en)

Adult Hematopoietic cell Stem cell Homograft Hematology Tyrosine kinase inhibitor Chronic myelogenous leukemia Prognosis Retrospective Allogeneic hematopoietic stem cell transplantation Hematopoietic stem cell transplantation Japan Cancer Human Malignant hemopathy Myeloproliferative syndrome Asia

Keyword (es)

Adulto Célula hematopoyética Célula primitiva Homoinjerto Hematología Inhibidor tyrosine kinase Leucemia mieloidea crónica Pronóstico Retrospectiva Aoinjerto de células precursoras hematopoyéticas Injerto de célula primitiva hematopoyética Japón Cáncer Hombre Hemopatía maligna Mieloproliferativo síndrome Asia

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Discipline

Blood diseases

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

28789706

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS